Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Switching between anti-TNFalpha agents: what is the evidence?

× No keyword cloud information.

3 in total

1. Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study.

Authors: Daniel E Furst; Norman Gaylis; Vance Bray; Ewa Olech; David Yocum; Jeffrey Ritter; Michael Weisman; Daniel J Wallace; John Crues; Dinesh Khanna; Gregory Eckel; Newman Yeilding; Peter Callegari; Sudha Visvanathan; Jeannie Rojas; Ronald Hegedus; Laura George; Khalid Mamun; Keith Gilmer; Orrin Troum
Journal: Ann Rheum Dis Date: 2007-04-05 Impact factor: 19.103

2. Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

Authors: Elisabeth Hjardem; Mikkel Østergaard; Jan Pødenphant; Ulrik Tarp; Lis Smedegaard Andersen; Jette Bing; Elisabeth Peen; Hanne Merete Lindegaard; Vibeke Stevenius Ringsdal; Anne Rødgaard; Jens Skøt; Annette Hansen; Hans Henrik Mogensen; Janne Unkerskov; Merete Lund Hetland
Journal: Ann Rheum Dis Date: 2007-03-27 Impact factor: 19.103

Review 3. ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature.

Authors: Stefano Alivernini; Antonella Laria; Elisa Gremese; Angelo Zoli; Gianfranco Ferraccioli
Journal: Arthritis Res Ther Date: 2009-11-03 Impact factor: 5.156

3 in total